Bangkok Tenofovir Study, an HIV Pre-exposure Prophylaxis Trial, Bangkok, Thailand
Study of the Safety and Efficacy of Daily Tenofovir to Prevent HIV Infection Among Injection Drug Users in Bangkok, Thailand
Sponsor: Bangkok Metropolitan Administration Medical College and Vajira Hospital
This PHASE2/PHASE3 trial investigates HIV Infections and is currently completed. Bangkok Metropolitan Administration Medical College and Vajira Hospital leads this study, which shows 9 recorded versions since 2005 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Dec 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Mar 2021 — Dec 2021 [monthly]
Completed PHASE2_PHASE3
-
Feb 2021 — Mar 2021 [monthly]
Completed PHASE2_PHASE3
▶ Show 4 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Completed PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2_PHASE3
First recorded
Jun 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bangkok Metropolitan Administration Medical College and Vajira Hospital
- Centers for Disease Control and Prevention
- Ministry of Health, Thailand
For direct contact, visit the study record on ClinicalTrials.gov .